Jae Chung

Doma Perpetual's 5.7% Stake in Pacira Biosciences: A Catalyst for Governance Change or Strategic Alignment? Doma Perpetual acquires 5.7% stake in Pacira, aiming to influence governance and strategy through board nominations. Investment includes $67.8M spent and three director nominees to enhance governance, aligning with Pacira's 5x30 growth plan. #shareholdervalue #corporategovernance #boardsofdirectors #activistinvesting https://lnkd.in/gfgu3Uw2

2

TheFounderVC has a truly compelling team - entrepreneurs and operators that have scaled from 0-1 and to exits across a variety of markets - some of whom are fellow classmates. They have built strong founder and VC networks over the last 25 years in tech and are now leveraging that access and experience on behalf of their portfolio. It clearly resonates with founders, as their early portfolio is truly compelling.

19

Health tech startups are scrambling to adapt as labor shortages and pricing pressures loom large. With EHR giants like Epic calling the shots, how are founders supposed to keep their heads above water while navigating this chaotic landscape? #HealthInnovation #DigitalHealth https://lnkd.in/gYbCjspE

1

We're excited to partner with A. J. Loiacono and the Judi Health (formerly Capital Rx) team as they close on $400M in new funding. Judi's vision for Unified Claims - across both medical and pharmacy - are an enormous step in the right direction in addressing some of the most pressing issues in healthcare infrastructure.

31

6 Comments

MedTech fundraising is tough, but it doesn’t have to be confusing. Too many startups focus on the science and leave fundraising strategy as an afterthought. The result? Costly mistakes, tough term sheets, and lost investor confidence. We put together this practical fundraising guide for MedTech founders covering: -Which funding options make sense early -How to navigate Angels vs. VCs -What every pitch deck must include -What investors really check in due diligence -How to plan your exit early The right strategy can mean the difference between a successful raise and months of frustration. Ready to get investor-ready? Book your FREE 30-min consultation with Adnan Ashfaq: https://simplimedica.com/ #MedTech #Fundraising #Startups #RegulatoryAffairs #MedicalDevices #HealthcareInnovation

2

If you’re building a health tech startup, here’s a useful perspective from the accelerator side. At ViVE, I spoke with Keith Camhi, Managing Director of the Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic States. The program invests in early-stage startups and helps founders run pilots with physicians in the Kaiser Permanente ecosystem. Some interesting takeaways: • Techstars still prioritizes “Team, team, team” above everything else; • Founders in the program are interviewed by physicians before acceptance; • The goal isn’t just mentorship — it’s getting real pilots with providers; • AI startups dominate applications, but the focus remains on real clinical problems. Applications for the next cohort open soon, so founders may want to keep an eye on it. Short interview from #ViVE 👇 🎥 Watch here: https://lnkd.in/gNN_5628 #Vive2026 #digitalhealthinsideout #health2tech #digitalhealth

41

1 Comment

Tarek Mouhieddine M.D. and I are excited to announce that POM Health is coming out of stealth today and opening a limited beta to early customers. We were founded with a simple mission of catching as many cancers as possible as early as possible and upgrading a cancer screening paradigm that too often catches disease late.  In the U.S., screening catches just ~14% of cancer cases, and around half of diagnoses are made at Stage III+. Despite having world-class detection technologies, we routinely screen for just 5 out of 200+ cancer types, often at multi-year intervals between screens, and most people won’t interact with an oncologist until there’s already a high suspicion of cancer. The result: 625k+ deaths from cancer annually in the US, 70% of which are in cancers without guideline-recommended screening, and far too many people believe their annual physical is an effective warning system. Elite cancer centers around the world (like where Tarek practices) have made significant advances in cancer detection and interception that have not yet translated to our primary care and insurance-driven screening system. With AI, we can now bring these advances to millions. Through POM Health, we offer access to more comprehensive cancer screening. Screening is led by world class oncologists, powered by AI, and accessible via telehealth, with one-time and annual subscription offerings.   POM's cancer screens use multiple detection modalities (including sample-based biomarkers, MCED, imaging, and genetics) to provide broad coverage across 90%+ of cancers, with overlapping coverage for 80%+. When a cancer signal is detected, your POM oncologist drives the next step quickly. The lifetime risk of acquiring cancer stands at 39% in the US and early onset cancers have doubled since 1990. Cancer isn't a rare disease and we believe people should have an option to mitigate their cancer risk.  Now serving beta test users in: MA, NY, and FL (CA soon, and waitlist open for all other states) Learn more: https://lnkd.in/e9qcaru9 Questions: lucas@pomhealth.xyz or tarek@pomhealth.xyz (POM = Peace of Mind, which everyone deserves when it comes to cancer) Thanks also to our first investor Leo Korsunsky!

44

8 Comments

I met Craig Limoli, Founder and CEO of Wellsheet, in 2019. Craig was presenting at the Ai4 Healthcare Conference in New York City, hosted by Michael J Weiss . It was one of those early gatherings focused on AI in healthcare - well before the recent wave of hype. Craig took the stage to share how Wellsheet was using AI to help doctors and nurses make better, faster decisions at the point of care with its Care Team Copilot. Wellsheet’s technology was impressive, but its real edge came from Craig’s deep understanding of the problem he was solving. Before founding Wellsheet, he worked at IBM as a strategy consultant, helping large health systems assess their tech stacks. He saw firsthand that the tools available were clunky, fragmented, and ultimately failed to support the clinicians doing the hardest work. It’s a story as old as time - the very systems IBM was selling to hospitals weren’t meeting their actual needs. So, Craig left IBM, enrolled in the The Wharton School MBA program to sharpen his entrepreneurial skills, and decided to build the product those systems truly needed - a Care Team Copilot designed to summarize patient charts, streamline documentation, and support real-time collaboration between physicians and nurses. We stayed in touch after that first meeting, and a few months later, Wellsheet raised its $4.5 million Series A, which our team at SpringTide Ventures led. The round came together just as the world was shutting down in the early months of the pandemic. Understandably, Craig was nervous that investors might pull back as uncertainty swept through the market, but we didn’t. We believed in Wellsheet’s mission, and more importantly, in Craig’s ability to execute against it. Despite the chaos of 2020, he stayed focused and transparent - qualities that made us even more confident we were backing the right founder at the right time. Fast forward to today: Wellsheet is now live at hundreds of hospitals and continues to outperform much larger competitors. In fact, when a major national health system evaluated solutions from both Google and Wellsheet, they unanimously chose Wellsheet. The healthcare industry faces an unprecedented shortage of doctors, nurses, and frontline clinicians. Wellsheet’s technology helps address this challenge by automating the most time-consuming and manual parts of clinical work. For physicians, it means no more laborious data entry; for executives, it means decisions are queued up for them - clear, informed, and ready to act on. By streamlining chart reviews, documentation, and decision support, Wellsheet enables care teams to focus on what truly matters: delivering better patient outcomes. We’re proud to support, and keep championing founders like Craig and his mission-driven team at Wellsheet!

117

6 Comments